📰 Impact Factor News
Page 7 - Impact Factor News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Impact Factor. Real-time updates on events, politics, business and more.
September 15, 2022
15.09.2022 - Obefazimod global pivotal phase 3 clinical program in ulcerative colitis on track with US IRB approval granted and first-patient-in expected end of September 2022Excellent results from the obefazimod phase 2b open-label maintenance study in moderate ...
September 9, 2022
According to Mayo Clinic Comprehensive Cancer Center researchers, metabolic imaging (FDG-PET) in combination with traditional treatment response assessment methods can provide clinicians with critical information they need to guide therapy for pancreatic cancer patients. Increasingly impactful nature of research in JNCCN reflected in new high for the journal's Impact Factor, now 12.693. PLYMOUTH MEETING, Pa., Sept. 9, 2022 /PRNewswire/ -- New research in the September 2022 issue of JNCCN-Jou...
September 8, 2022
/PRNewswire/ -- New research in the September 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network finds the use of positron emission...
September 8, 2022
According to Mayo Clinic Comprehensive Cancer Center researchers, metabolic imaging (FDG-PET) in combination with traditional treatment response assessment methods can provide clinicians with
September 8, 2022
According to Mayo Clinic Comprehensive Cancer Center researchers, metabolic imaging (FDG-PET) in combination with traditional treatment response assessment methods can provide clinicians with critical information they need to guide therapy for pancreatic cancer patients. Increasingly impactful nature of research in JNCCN reflected in new high for the journal's Impact Factor, now 12.693. PLYMOUTH MEETING, Pa., Sept. 9, 2022 /PRNewswire/ -- New research in the September 2022 issue of JNCCN-Jou...
September 6, 2022
DGAP-News: ABIVAX / Key word(s): Study Abivax phase 2b study results of obefazimod (ABX464) in ulcerative colitis published in the La...
September 6, 2022
DGAP-News: ABIVAX / Key word(s): StudyAbivax phase 2b study results of obefazimod (ABX464) in ulcerative colitis published in the Lancet Gastroenterology & Hepatology 06.09.2022 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement.ABIVAX PHASE 2B STUDY RESULTS OF OBEFAZIMOD (ABX4...
September 5, 2022
I’ll admit it up front, statistics has never been my forte. I belong to a generation that was poorly educated on the topic. The courses I took focused on frequentist probability. The lectures were…
August 30, 2022
The Next-Generation Battery Research Center of the Korea Electrotechnology Research Institute conducted a study on Li-metal batteries, which was later published as a cover paper in a prestigious international journal.
August 8, 2022
Findings support utility of QTY protein code as a novel platform to generate water-soluble proteins for wide spectrum of biomedical applications Reports plans to apply for additional patents... | August 8, 2022